Valuation
- Market cap
- 55,384,320,000
- Revenue TTM
- $18,106,560,000
- Net income TTM
- $1,822,290,000
- P/E (trailing)
- 0.00
- P/E (forward)
- 16.74
- Profit margin
- 10.06%
- Debt to equity
- 1.46
Trading
- Volume
- 231,100
- Avg volume
- 364,230
- Day's range
- $17.07 – $17.29
- Shares out
- 3,223,767,000
- Stochastic %K
- 18%
- Beta
- 0.38
- Analysts
- Moderate Buy
- Price target
- $15.68
Company profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, mineral...
Show more
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- Phone
- 44 17 5321 7800
- Website
- https://www.reckitt.com
- Address
- Turner House, 103-105 Bath Road, Slough, United Kingdom
Latest news
No headlines yet.
